Invesco Ltd. Catalent, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Catalent, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 2,905,759 shares of CTLT stock, worth $184 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,905,759

Previous 2,733,551 6.3%

Holding current value

$184 Million

Previous $154 Million 14.5%

% of portfolio

0.04%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$56.16 - $60.96 $9.67 Million - $10.5 Million	172,208 Added 6.3%	2,905,759 $176 Million
Q2 2024 Aug 13, 2024	SELL	$53.58 - $57.02 $21.9 Million - $23.3 Million	-408,485 Reduced 13.0%	2,733,551 $154 Million
Q1 2024 May 14, 2024	SELL	$42.56 - $59.82 $28.9 Million - $40.6 Million	-679,175 Reduced 17.77%	3,142,036 $177 Million
Q4 2023 Feb 12, 2024	BUY	$32.18 - $46.57 $32.6 Million - $47.2 Million	1,013,079 Added 36.08%	3,821,211 $172 Million
Q3 2023 Nov 13, 2023	SELL	$44.2 - $50.2 $18.8 Million - $21.3 Million	-424,248 Reduced 13.12%	2,808,132 $128 Million
Q2 2023 Aug 11, 2023	SELL	$31.86 - $67.26 $10.6 Million - $22.4 Million	-333,086 Reduced 9.34%	3,232,380 $140 Million
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $1.38 Million - $2.25 Million	30,346 Added 0.86%	3,565,466 $234 Million
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $50.4 Million - $98.7 Million	1,218,838 Added 52.62%	3,535,120 $159 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $43.2 Million - $67.5 Million	-596,718 Reduced 20.48%	2,316,282 $168 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $55.8 Million - $73 Million	-640,433 Reduced 18.02%	2,913,000 $313 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $20.3 Million - $26.8 Million	214,992 Added 6.44%	3,553,433 $394 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $58.3 Million - $67.8 Million	-487,352 Reduced 12.74%	3,338,441 $427 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $60.1 Million - $78.4 Million	-550,973 Reduced 12.59%	3,825,793 $509 Million
Q2 2021 Aug 17, 2021	SELL	$100.34 - $115.69 $7.7 Million - $8.88 Million	-76,788 Reduced 1.72%	4,376,766 $473 Million
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $86.2 Million - $106 Million	849,364 Added 23.57%	4,453,554 $469 Million
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $31.9 Million - $39.1 Million	-371,055 Reduced 9.33%	3,604,190 $375 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $75.2 Million - $95.6 Million	1,033,708 Added 35.14%	3,975,245 $341 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $20.9 Million - $34.3 Million	434,396 Added 17.33%	2,941,537 $216 Million
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $20.9 Million - $35.6 Million	566,273 Added 29.18%	2,507,141 $130 Million
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $11.9 Million - $14.4 Million	253,617 Added 15.03%	1,940,868 $109 Million
Q3 2019 Nov 14, 2019	SELL	$47.45 - $58.05 $4.15 Million - $5.08 Million	-87,515 Reduced 4.93%	1,687,251 $80.4 Million
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $7.42 Million - $10.2 Million	188,998 Added 11.92%	1,774,766 $96.2 Million
Q1 2019 May 15, 2019	SELL	$29.84 - $43.92 $1.62 Million - $2.39 Million	-54,454 Reduced 3.32%	1,585,768 $64.4 Million
Q4 2018 Feb 14, 2019	BUY	$29.95 - $46.34 $49.1 Million - $76 Million	1,640,222 New	1,640,222 $51.1 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account